Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Hyperglycemia 1Congenital Abnormalities 1

Interventions

Peripheral Blood Stem Cell Transplantation 6fludarabine phosphate 4Radiotherapy 3Mycophenolic Acid 3Cyclosporine 3Whole-Body Irradiation 2Therapeutics 2Tacrolimus 2Pentetic Acid 2Methotrexate 2Cyclophosphamide 2Busulfan 2ethanolamine oleate 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Transplantation 1Thiotepa 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Psychiatric Rehabilitation 1Pentostatin 1Minocycline 1Melphalan 1Insulin Glargine 1Insulin 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Congenital Abnormalities × Insulin Glargine × Clear all
NCT00943709 2013-08-30

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

Rutgers, The State University of New Jersey

Phase 3 Withdrawn
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Hyperglycemia, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡